MENINGOCOCCAL MENINGITIS

More documents

Recommendations

Info

Who is at risk? Healthy individuals Increased risk in Children 6 months – 4 years Complement deficiencies Splenectomy patients Patients taking immunosuppressive drugs Current viral infection
Incubation period and Infectivity Incubation period: 2-10 2 10 days Infectivity period: as long as the organism is present in the nasopharynx. nasopharynx. Reservoir: is man and the organism dies quickly outside the host.
Page 1 and 2: MENINGOCOCCAL MENINGITIS Dr. Charma
Page 3 and 4: Types of Meningitis
Page 5 and 6: Meningococcal Disease Severe bacte
Page 7 and 8: Aetiological agent The causative a
Page 9 and 10: Neisseria meningitidis 3 serogroups
Page 11: Nasopharyngeal carriage Neisseria
Page 15 and 16: Signs and Symptoms Meningococcal Me
Page 17 and 18: Petechial rash
Page 19 and 20: Necrotic rash
Page 21 and 22: Petechial rash
Page 23 and 24: Other signs and symptoms Acute fev
Page 25 and 26: “Meningitis Meningitis belt” be
Page 27 and 28: Meningococcal disease Statuatory n
Page 29 and 30: Collect Information Record basic in
Page 31 and 32: Case ascertainment EU Case Definit
Page 33 and 34: Case classification Probable case:
Page 35 and 36: Family Slide
Page 37 and 38: Prophylactic treatment Risk assess
Page 39 and 40: Prophylaxis NOT indicated Staff an
Page 41 and 42: Chemoprophylaxis : CIPROFLOXACIN 5
Page 43 and 44: Dissemination of information House
Page 45 and 46: Managing clusters Assess the infor
Page 47 and 48: Control Strategy Communicable dise
Page 49 and 50: Case fatality rate Proportion of c
Page 51 and 52: AGE SPECIFIC INCIDENCE RATES Incide
Page 53: Thank you charmaine.gauci@gov.mt

MENINGOCOCCAL MENINGITIS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?